搜尋結果
- 消委會相關文章 - 雅虎香港
Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account and ...
Product Highlights. Spikevax XBB.1.5. Contents : Andusomeran [COVID-19 mRNA vaccine (nucleoside modified)] Indications/Uses : Active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals ≥12 yr. Enhertu. Contents : Trastuzumab deruxtecan.
Drug Name and Description. SEARCH. Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India.
Drug Interactions. Affected by debrisoquine; guanethidine, MAOIs, reserpine & methyldopa, tricyclic antidepressants. MIMS Class. Cough & Cold Preparations. ATC Classification. R05DA20 - combinations ; Belongs to the class of opium alkaloids and derivatives. Used as cough suppressant. Regulatory Classification. P 1 S 1. Presentation/Packing. Form.
10 mg once daily. Patient w/ severe hepatic impairment Initially 5 mg, may be increased to 10 mg if well tolerated. Click to view Forxiga detailed prescribing information. Overdosage. View Forxiga overdosage for action to be taken in the event of an overdose. Administration. May be taken with or without food. Contraindications. Hypersensitivity.
Contents. Bilastine. Indications/Uses. Symptomatic treatment of allergic rhino-conjunctivitis (seasonal & perennial) & urticaria. 20 mg tab For adult & adolescents ≥12 yr. 10 mg orodispersible tab (ODT) For childn 6-11 yr w/ body wt of at least 20 kg. Click to view Labixten detailed prescribing information. Dosage/Direction for Use.
SC Primary hypercholesterolaemia & mixed dyslipidaemia (including HeFH) Adult & paed ≥10 yr 140 mg every 2 wk or 420 mg once mthly. HoFH Adult & paed ≥10 yr Initially 420 mg once mthly, can be up-titrated to 420 mg once every 2 wk if clinically meaningful response is not achieved after 12 wk. Patient on apheresis May initiate treatment w ...
